This is a Validated Antibody Database (VAD) review about dogs VEGFA, based on 41 published articles (read how Labome selects the articles), using VEGFA antibody in all methods. It is aimed to help Labome visitors find the most suited VEGFA antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
VEGFA synonym: VEGF

Knockout validation
Invitrogen
mouse monoclonal (VG1)
  • western blot knockout validation; human; loading ...; fig 2a
  • immunohistochemistry; human; 1:200; loading ...; fig 9a
Invitrogen VEGFA antibody (Thermo Fisher Scientific, MA1-16629) was used in western blot knockout validation on human samples (fig 2a) and in immunohistochemistry on human samples at 1:200 (fig 9a). Sci Rep (2020) ncbi
Abcam
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; mouse; loading ...; fig s5c
  • western blot; mouse; loading ...; fig 8c
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on mouse samples (fig s5c) and in western blot on mouse samples (fig 8c). iScience (2022) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:200; loading ...; fig 7e
  • western blot; human; 1:1000; loading ...; fig 1i, 2e
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:200 (fig 7e) and in western blot on human samples at 1:1000 (fig 1i, 2e). Stem Cell Res Ther (2021) ncbi
mouse monoclonal (VG-1)
  • western blot; mouse; 1:500; loading ...; fig 5
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on mouse samples at 1:500 (fig 5). J Orthop Surg Res (2021) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; mouse; loading ...; fig 3c
  • immunohistochemistry - paraffin section; human; loading ...; fig 3d
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on mouse samples (fig 3c) and in immunohistochemistry - paraffin section on human samples (fig 3d). Oncogene (2021) ncbi
mouse monoclonal (VG-1)
  • western blot; human; loading ...; fig 6d
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on human samples (fig 6d). PLoS Genet (2020) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry; rat; 1:25; loading ...; fig 4d
  • western blot; rat; 1:1000; loading ...; fig 5a
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry on rat samples at 1:25 (fig 4d) and in western blot on rat samples at 1:1000 (fig 5a). Mol Med Rep (2017) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:100; fig 5
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:100 (fig 5). Braz J Med Biol Res (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; mouse; fig 6
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on mouse samples (fig 6). Sci Rep (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; domestic rabbit; 1:1000; fig 7
Abcam VEGFA antibody (abcam, ab1316) was used in western blot on domestic rabbit samples at 1:1000 (fig 7). Mol Med Rep (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; human; fig 5
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on human samples (fig 5). BMC Complement Altern Med (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2a
Abcam VEGFA antibody (Abcam, VG-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2a). BMC Cancer (2015) ncbi
mouse monoclonal (VG-1)
  • western blot; rat; fig f4b
In order to examine the effect of advanced glycation end products on the retina, Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on rat samples (fig f4b). Mol Med Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; mouse; 1:200; fig 5
  • western blot; mouse; 1:300; fig 6
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on mouse samples at 1:200 (fig 5) and in western blot on mouse samples at 1:300 (fig 6). Sci Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; mouse; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on mouse samples at 1:1000. Reprod Sci (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; loading ...; fig 1a
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples (fig 1a). Onco Targets Ther (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; mouse; 1:500; tbl 6
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on mouse samples at 1:500 (tbl 6). PLoS ONE (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; domestic rabbit; 1:500; loading ...; fig 4
  • ELISA; domestic rabbit; 1:500; loading ...; fig 1
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on domestic rabbit samples at 1:500 (fig 4) and in ELISA on domestic rabbit samples at 1:500 (fig 1). Oncol Lett (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - frozen section; human; 1:200; fig 4
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - frozen section on human samples at 1:200 (fig 4). Mol Med Rep (2015) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:200; fig 2
Abcam VEGFA antibody (AbCam, VG-1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 2). BMC Cancer (2014) ncbi
mouse monoclonal (VG-1)
  • western blot; rat; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in western blot on rat samples at 1:1000. PLoS ONE (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:1000
  • western blot; rat; 1:1000
In order to investigate the mechanisms by which mesenchymal stem cells alleviate acute liver failure in rats, Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:1000 and in western blot on rat samples at 1:1000. Genet Mol Res (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; rat; 1:100
  • western blot; rat; 1:2000
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on rat samples at 1:100 and in western blot on rat samples at 1:2000. PLoS ONE (2014) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:100
In order to study the involvement of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma, Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Mol Sci (2014) ncbi
mouse monoclonal (VG-1)
  • blocking or activating experiments; mouse
Abcam VEGFA antibody (Abcam, ab1316) was used in blocking or activating experiments on mouse samples . J Biomed Res (2012) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry - paraffin section; human; 1:100
Abcam VEGFA antibody (Abcam, ab1316) was used in immunohistochemistry - paraffin section on human samples at 1:100. Oncol Lett (2013) ncbi
mouse monoclonal (VG-1)
  • ELISA; rat; 1:1000
Abcam VEGFA antibody (Abcam, ab1316) was used in ELISA on rat samples at 1:1000. Microvasc Res (2012) ncbi
Santa Cruz Biotechnology
mouse monoclonal (SPM225)
  • immunohistochemistry - paraffin section; human; 1:100; loading ...; fig 4g
Santa Cruz Biotechnology VEGFA antibody (Santa Cruz, sc-65617) was used in immunohistochemistry - paraffin section on human samples at 1:100 (fig 4g). Front Oncol (2022) ncbi
mouse monoclonal (VG-1)
  • western blot; mouse; 1:200; loading ...; fig 1c
Santa Cruz Biotechnology VEGFA antibody (Santa Cruz, Sc-53462) was used in western blot on mouse samples at 1:200 (fig 1c). Sci Rep (2020) ncbi
mouse monoclonal (VG-1)
  • western blot; human; loading ...; fig 5a
Santa Cruz Biotechnology VEGFA antibody (Santa Cruz Biotechnology, sc53462) was used in western blot on human samples (fig 5a). Exp Cell Res (2019) ncbi
mouse monoclonal (VG-1)
  • western blot; rat; fig 7
Santa Cruz Biotechnology VEGFA antibody (santa Cruz, sc-53462) was used in western blot on rat samples (fig 7). BMC Cancer (2016) ncbi
mouse monoclonal (VG-1)
  • western blot; mouse; fig 8
  • western blot; human; fig 4
In order to learn about inhibition of stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/beta-catenin signaling axis via cucurbitacin B, Santa Cruz Biotechnology VEGFA antibody (Santa Cruz, S C-53462) was used in western blot on mouse samples (fig 8) and in western blot on human samples (fig 4). Sci Rep (2016) ncbi
mouse monoclonal (VG-1)
  • immunohistochemistry; rat
Santa Cruz Biotechnology VEGFA antibody (Santa Cruz biotechnology, sc-53462) was used in immunohistochemistry on rat samples . Biochem Biophys Res Commun (2014) ncbi
Invitrogen
mouse monoclonal (VG1)
  • western blot; human; 1:200; loading ...; fig 5a
Invitrogen VEGFA antibody (Thermo Scientific, MA1-16629) was used in western blot on human samples at 1:200 (fig 5a). Cancers (Basel) (2021) ncbi
mouse monoclonal (VG1)
  • western blot knockout validation; human; loading ...; fig 2a
  • immunohistochemistry; human; 1:200; loading ...; fig 9a
Invitrogen VEGFA antibody (Thermo Fisher Scientific, MA1-16629) was used in western blot knockout validation on human samples (fig 2a) and in immunohistochemistry on human samples at 1:200 (fig 9a). Sci Rep (2020) ncbi
mouse monoclonal (VG1)
  • immunocytochemistry; mouse; fig 3
In order to study proteins absent in the eyes during pathological and developmental angiogenesis, Invitrogen VEGFA antibody (ThermoFisher Scientific, VG1) was used in immunocytochemistry on mouse samples (fig 3). Am J Pathol (2016) ncbi
mouse monoclonal (VG1)
  • western blot; rat; 1:200
In order to investigate the benefits of replacing a PMMA spacer with a semi-flexible medical grade silicone spacer for long bone defect reconstruction, Invitrogen VEGFA antibody (Thermo, MA1-16629) was used in western blot on rat samples at 1:200. Acta Biomater (2015) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; 1:50
In order to use Romanian patients with gastric carcinomas and compare the demographic, clinical, and immunohistochemical aspects of each cancer, Invitrogen VEGFA antibody (LabVision, VG1) was used in immunohistochemistry - paraffin section on human samples at 1:50. APMIS (2015) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; 1:200; tbl 2
In order to report the clinicopathological features of 9 breast malignant fibrous histiocytoma patients, Invitrogen VEGFA antibody (Lab Vision, VG1) was used in immunohistochemistry - paraffin section on human samples at 1:200 (tbl 2). Sci Rep (2013) ncbi
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; human; fig 1
In order to investigate the parameters for the identification of multiple myeloma patients suitable for bortezomib therapy, Invitrogen VEGFA antibody (Zymed, VG1) was used in immunohistochemistry - paraffin section on human samples (fig 1). Clin Cancer Res (2009) ncbi
Novus Biologicals
mouse monoclonal (VG1)
  • immunohistochemistry; rat; 1:50; loading ...
Novus Biologicals VEGFA antibody (Novus Biologicals, NB100-664) was used in immunohistochemistry on rat samples at 1:50. PLoS ONE (2021) ncbi
Abnova
mouse monoclonal (VG1)
  • immunohistochemistry - paraffin section; rat; 1:800; loading ...; fig st15
  • immunohistochemistry - paraffin section; human; 1:800; loading ...; fig st15
In order to outline the protocols for antibodies used for immunohistochemical studies, Abnova VEGFA antibody (Abnova MAB6996, MAB6996) was used in immunohistochemistry - paraffin section on rat samples at 1:800 (fig st15) and in immunohistochemistry - paraffin section on human samples at 1:800 (fig st15). J Toxicol Pathol (2017) ncbi
Articles Reviewed
  1. Pandey S, Shteinfer Kuzmine A, Chalifa Caspi V, Shoshan Barmatz V. Non-apoptotic activity of the mitochondrial protein SMAC/Diablo in lung cancer: Novel target to disrupt survival, inflammation, and immunosuppression. Front Oncol. 2022;12:992260 pubmed publisher
  2. Du M, Wang C, Yang L, Liu B, Zheng Z, Yang L, et al. The role of long noncoding RNA Nron in atherosclerosis development and plaque stability. iScience. 2022;25:103978 pubmed publisher
  3. Shen J, Sun Y, Liu X, Zhu Y, Bao B, Gao T, et al. EGFL6 regulates angiogenesis and osteogenesis in distraction osteogenesis via Wnt/β-catenin signaling. Stem Cell Res Ther. 2021;12:415 pubmed publisher
  4. Qian J, Xu Q, Xu W, Cai R, Huang G. Expression of VEGF-A Signaling Pathway in Cartilage of ACLT-induced Osteoarthritis Mouse Model. J Orthop Surg Res. 2021;16:379 pubmed publisher
  5. Shen M, Zhang R, Jia W, Zhu Z, Zhao X, Zhao L, et al. Nuclear scaffold protein p54nrb/NONO facilitates the hypoxia-enhanced progression of hepatocellular carcinoma. Oncogene. 2021;40:4167-4183 pubmed publisher
  6. Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
  7. Sene L, Scarano W, Zapparoli A, Gontijo J, Boer P. Impact of gestational low-protein intake on embryonic kidney microRNA expression and in nephron progenitor cells of the male fetus. PLoS ONE. 2021;16:e0246289 pubmed publisher
  8. Attaai A, Noreldin A, Abdel Maksoud F, Hussein M. An updated investigation on the dromedary camel cerebellum (Camelus dromedarius) with special insight into the distribution of calcium-binding proteins. Sci Rep. 2020;10:21157 pubmed publisher
  9. Mulcrone P, Edwards S, Petrusca D, Haneline L, Delgado Calle J, Roodman G. Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23. Sci Rep. 2020;10:17319 pubmed publisher
  10. Gao P, Wang D, Liu M, Chen S, Yang Z, Zhang J, et al. DNA methylation-mediated repression of exosomal miR-652-5p expression promotes oesophageal squamous cell carcinoma aggressiveness by targeting PARG and VEGF pathways. PLoS Genet. 2020;16:e1008592 pubmed publisher
  11. Guan H, Li N, Wang X, Shan X, Li Z, Lin Z. Role of Paip1 on angiogenesis and invasion in pancreatic cancer. Exp Cell Res. 2019;376:198-209 pubmed publisher
  12. Furukawa S, Nagaike M, Ozaki K. Databases for technical aspects of immunohistochemistry. J Toxicol Pathol. 2017;30:79-107 pubmed publisher
  13. Zhang H, Zhang P, Gao Y, Li C, Wang H, Chen L, et al. Early VEGF inhibition attenuates blood-brain barrier disruption in ischemic rat brains by regulating the expression of MMPs. Mol Med Rep. 2017;15:57-64 pubmed publisher
  14. Garcia P, Seiva F, Carniato A, de Mello Júnior W, Duran N, Macedo A, et al. Increased toll-like receptors and p53 levels regulate apoptosis and angiogenesis in non-muscle invasive bladder cancer: mechanism of action of P-MAPA biological response modifier. BMC Cancer. 2016;16:422 pubmed publisher
  15. Li X, Chen Y, Wang L, Shang G, Zhang C, Zhao Z, et al. Quercetin alleviates pulmonary angiogenesis in a rat model of hepatopulmonary syndrome. Braz J Med Biol Res. 2016;49: pubmed publisher
  16. Chung S, Gillies M, Yam M, Wang Y, Shen W. Differential expression of microRNAs in retinal vasculopathy caused by selective Müller cell disruption. Sci Rep. 2016;6:28993 pubmed publisher
  17. Wang Y, Li Y, Song L, Li Y, Jiang S, Zhang S. The transplantation of Akt-overexpressing amniotic fluid-derived mesenchymal stem cells protects the heart against ischemia-reperfusion injury in rabbits. Mol Med Rep. 2016;14:234-42 pubmed publisher
  18. Abu N, Akhtar M, Yeap S, Lim K, Ho W, Abdullah M, et al. Flavokawain B induced cytotoxicity in two breast cancer cell lines, MCF-7 and MDA-MB231 and inhibited the metastatic potential of MDA-MB231 via the regulation of several tyrosine kinases In vitro. BMC Complement Altern Med. 2016;16:86 pubmed publisher
  19. Shukla S, Sinha S, Khan S, Kumar S, Singh K, Mitra K, et al. Cucurbitacin B inhibits the stemness and metastatic abilities of NSCLC via downregulation of canonical Wnt/β-catenin signaling axis. Sci Rep. 2016;6:21860 pubmed publisher
  20. Wang Y, Tadjuidje E, Pandey R, Stefater J, Smith L, Lang R, et al. The Eyes Absent Proteins in Developmental and Pathological Angiogenesis. Am J Pathol. 2016;186:568-78 pubmed publisher
  21. Pinheiro C, Garcia E, Morais Santos F, Moreira M, Almeida F, Jubé L, et al. Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. BMC Cancer. 2015;15:835 pubmed publisher
  22. Kim C, Kim J, Jo K, Lee Y, Sohn E, Yoo N, et al. OSSC1E-K19, a novel phytochemical component of Osteomeles schwerinae, prevents glycated albumin-induced retinal vascular injury in rats. Mol Med Rep. 2015;12:7279-84 pubmed publisher
  23. Yang S, He H, Ma Q, Zhang Y, Zhu Y, Wan X, et al. Experimental study of the protective effects of SYVN1 against diabetic retinopathy. Sci Rep. 2015;5:14036 pubmed publisher
  24. Bacallao K, Plaza Parrochia F, Cerda A, Gabler F, Romero C, Vantman D, et al. Levels of Regulatory Proteins Associated With Cell Proliferation in Endometria From Untreated Patients Having Polycystic Ovarian Syndrome With and Without Endometrial Hyperplasia. Reprod Sci. 2016;23:211-8 pubmed publisher
  25. Li C, Wang L, Zheng L, Zhan X, Xu B, Jiang J, et al. SIRT1 expression is associated with poor prognosis of lung adenocarcinoma. Onco Targets Ther. 2015;8:977-84 pubmed publisher
  26. Chan N, He S, Spee C, Ishikawa K, Hinton D. Attenuation of choroidal neovascularization by histone deacetylase inhibitor. PLoS ONE. 2015;10:e0120587 pubmed publisher
  27. de Monès E, Schlaubitz S, Oliveira H, d Elbée J, Bareille R, Bourget C, et al. Comparative study of membranes induced by PMMA or silicone in rats, and influence of external radiotherapy. Acta Biomater. 2015;19:119-27 pubmed publisher
  28. Qi J, Wang W, Li F. Combination of interventional adenovirus-p53 introduction and ultrasonic irradiation in the treatment of liver cancer. Oncol Lett. 2015;9:1297-1302 pubmed
  29. Gurzu S, Kádár Z, Sugimura H, Bara T, Hălmaciu I, Jung I. Gastric cancer in young vs old Romanian patients: immunoprofile with emphasis on maspin and mena protein reactivity. APMIS. 2015;123:223-33 pubmed publisher
  30. Yuan L, Liu X. Platelets are associated with xenograft tumor growth and the clinical malignancy of ovarian cancer through an angiogenesis-dependent mechanism. Mol Med Rep. 2015;11:2449-58 pubmed publisher
  31. Pinheiro C, Garcia E, Morais Santos F, Scapulatempo Neto C, Mafra A, Steenbergen R, et al. Lactate transporters and vascular factors in HPV-induced squamous cell carcinoma of the uterine cervix. BMC Cancer. 2014;14:751 pubmed publisher
  32. Aeimlapa R, Wongdee K, Charoenphandhu N, Suntornsaratoon P, Krishnamra N. Premature chondrocyte apoptosis and compensatory upregulation of chondroregulatory protein expression in the growth plate of Goto-Kakizaki diabetic rats. Biochem Biophys Res Commun. 2014;452:395-401 pubmed publisher
  33. Shen W, Chung S, Irhimeh M, Li S, Lee S, Gillies M. Systemic administration of erythropoietin inhibits retinopathy in RCS rats. PLoS ONE. 2014;9:e104759 pubmed publisher
  34. Yuan S, Jiang T, Sun L, Zheng R, Cao G, Ahat N, et al. Use of bone mesenchymal stem cells to treat rats with acute liver failure. Genet Mol Res. 2014;13:6962-80 pubmed publisher
  35. Bai X, Li X, Tian J, Zhou Z. Antiangiogenic treatment diminishes renal injury and dysfunction via regulation of local AKT in early experimental diabetes. PLoS ONE. 2014;9:e96117 pubmed publisher
  36. Ferreira C, Siqueira D, Romitti M, Ceolin L, Brasil B, Meurer L, et al. Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma. Int J Mol Sci. 2014;15:5323-36 pubmed publisher
  37. Qiu S, Wei X, Huang W, Wu M, Qin Y, Li Y, et al. Diagnostic and therapeutic strategy and the most efficient prognostic factors of breast malignant fibrous histiocytoma. Sci Rep. 2013;3:2529 pubmed publisher
  38. Xu W, Fan W, Yao K. Cyclosporine A stimulated hair growth from mouse vibrissae follicles in an organ culture model. J Biomed Res. 2012;26:372-80 pubmed publisher
  39. Wang W, Jiang H, Zhu H, Zhang H, Gong J, Zhang L, et al. Overexpression of high mobility group box 1 and 2 is associated with the progression and angiogenesis of human bladder carcinoma. Oncol Lett. 2013;5:884-888 pubmed
  40. Tripathy D, Sanchez A, Yin X, Martinez J, Grammas P. Age-related decrease in cerebrovascular-derived neuroprotective proteins: effect of acetaminophen. Microvasc Res. 2012;84:278-85 pubmed publisher
  41. Dawson M, Opat S, Taouk Y, Donovan M, Zammit M, Monaghan K, et al. Clinical and immunohistochemical features associated with a response to bortezomib in patients with multiple myeloma. Clin Cancer Res. 2009;15:714-22 pubmed publisher